You've cleaned up your diet. You're taking a multivitamin. Maybe you've added magnesium, ashwagandha, a B-complex, and now — because the internet keeps telling you to — an NAD+ precursor like NR or NMN. Your supplement drawer looks like a small pharmacy. And yet, by 3 p.m., you're still flat.

If that's where you are, the issue probably isn't that you need another supplement. The issue is that the fatigue is being misdiagnosed. NAD+ has become the catch-all explanation for low energy, but in most people it isn't the bottleneck. Before we talk about why, let's clarify what fatigue actually is from a clinical standpoint.

What Fatigue Actually Is

"Tired" is a symptom, not a diagnosis. In practice, persistent fatigue almost always traces back to one of a handful of underlying mechanisms — and each one has a different fix.

Iron deficiency, including functional deficiency. Low ferritin can cause fatigue long before hemoglobin drops enough to flag anemia on standard labs. Functional iron deficiency — where iron is present but unavailable for use due to inflammation — is also common and frequently missed. If ferritin is under ~30 ng/mL (some clinicians use higher cutoffs), fatigue is a reasonable expectation regardless of what supplements you take.

Thyroid dysfunction. Subclinical hypothyroidism, Hashimoto's, and undertreated thyroid disease produce a kind of fatigue that no amount of NAD+ will touch. TSH alone is not enough; free T4, free T3, and antibodies often need to be considered.

Cortisol dysregulation. Chronic stress flattens the natural cortisol curve. People wake up exhausted, get a second wind at night, and can't fall asleep. This pattern is behavioral and physiological — not a precursor deficiency.

Sleep architecture issues. You can spend eight hours in bed and still wake up tired if your sleep is fragmented, if you have undiagnosed sleep apnea, or if alcohol is suppressing REM. Sleep quantity without sleep quality is one of the most common reasons people feel chronically depleted.

Mitochondrial dysfunction. This is where NAD+ enters the conversation. Mitochondria produce ATP, the body's actual energy currency, and NAD+ is a coenzyme central to that process. When mitochondrial output drops — with age, in metabolic disease, or under sustained oxidative stress — fatigue can follow. The question is whether boosting NAD+ in healthy adults actually fixes that bottleneck. We'll get to it.

NAD+, Explained Simply

NAD+ (nicotinamide adenine dinucleotide) is a coenzyme present in every cell. Two of its jobs matter for the fatigue conversation: it shuttles electrons through the electron transport chain to help generate ATP, and it serves as a substrate for sirtuins and PARPs — enzymes involved in DNA repair and stress response.

NAD+ levels decline with age. They also drop in conditions involving chronic inflammation, metabolic dysfunction, and cellular stress. From there, the logic is intuitive: if NAD+ goes down and energy goes down, raise NAD+ and energy should come back up.

That logic is what built an entire supplement category. The problem is that biology isn't always that linear.

What the Research Actually Shows

The current human evidence — primarily small, short randomized controlled trials and a few systematic reviews from 2023–2026 — is consistent on one point and frustratingly inconsistent on another.

Consistent finding: NR and NMN reliably raise NAD+ in the blood. A 2026 PRISMA systematic review by Gallagher and colleagues, covering 33 human intervention studies, confirmed that oral NR and NMN engage the target. Zhang and colleagues (2025) reached the same conclusion in their meta-analysis. If the question is "does the supplement get into your system and shift the biomarker," the answer is yes.

Inconsistent finding: clinical outcomes don't reliably follow. That same 2026 review described the functional, metabolic, and vascular outcomes as heterogeneous and "often null or endpoint-specific." VO2max and grip strength were frequently unchanged. Fatigue and sleep results were mixed — some self-reported improvements, others nothing. The reviewers concluded that biochemical activity is clear, but clinical effectiveness for anti-aging and wellness use is inconclusive.

The long-COVID trial by Wu and colleagues (2025) is worth highlighting because it tested high-dose NR (2000 mg/day) in a population with persistent fatigue and cognitive symptoms — exactly the kind of patient who would, in theory, benefit. NAD+ rose 2.6 to 3.1 fold. And in the primary analysis, there was no significant between-group difference versus placebo for cognition, fatigue severity (p=0.59), sleep quality, or mood. Post-hoc within-group exploratory signals were noted, but the headline result was a null finding despite clear target engagement.

A more positive outlier is the Yi et al. (2023) RCT in healthy middle-aged adults, where 60 days of NMN at 300, 600, or 900 mg/day produced dose-dependent increases in NAD+ and significant improvement in 6-minute walk distance and self-reported health. So benefits are not zero — but they show up in submaximal performance and subjective measures, not in the broad "I have more energy" sense people are usually chasing.

The pattern is clear once you step back: the biomarker moves, but the person often doesn't feel different.

Why People Feel No Difference

A few things are likely happening at once.

The most common reason is the simplest one: the wrong root cause is being treated. If your fatigue is driven by low ferritin, undertreated thyroid disease, fragmented sleep, or chronic stress, raising NAD+ does not address any of those. You can saturate the pathway and still feel exhausted because the actual rate-limiting step is somewhere else entirely.

Second, NAD+ may not be the limiting factor in healthy adults to begin with. Cellular NAD+ pools are tightly regulated, and in someone without significant metabolic dysfunction, pushing levels higher doesn't necessarily change downstream output. More substrate doesn't help if the bottleneck is elsewhere on the assembly line.

Third, there are real questions about absorption and tissue targeting. Raising circulating NAD+ metabolites is not the same as raising NAD+ in the specific tissues — muscle, brain, liver — where it would need to act to change how you feel. Human pharmacokinetic data here is still maturing.

And fourth, there's a mismatch between expectation and biology. People expect a felt difference, the kind a stimulant produces. NAD+ precursors, even when they help, work slowly and at the level of cellular metabolism. That is not a sensation you can feel by Tuesday.

When NAD+ Might Actually Help

There are populations where the rationale is stronger and the data is more encouraging.

Older adults — particularly those over 60 — have measurably lower NAD+ levels and may see more functional benefit, especially in submaximal physical performance. Yi et al. fits this picture.

People with metabolic dysfunction, including insulin resistance and obesity, are another group where mitochondrial bottlenecks are more plausible and supplementation has a clearer mechanistic argument, though clinical trial outcomes remain mixed.

And in high-stress or burnout cases, where chronic cortisol elevation and sleep disruption have likely degraded mitochondrial function over time, NAD+ support as part of a larger plan is reasonable to consider. The key phrase is "part of a larger plan." It is not the foundation.

What I Would Actually Recommend, As a Pharmacist

When someone walks up to the counter exhausted, holding a bottle of NMN, here's the order of operations I'd actually use.

First, fix sleep. Not sleep quantity — sleep quality. Consistent schedule, cool dark room, no alcohol within three hours of bed, and a serious conversation about sleep apnea if there's snoring, witnessed pauses, or daytime sleepiness despite adequate hours. No supplement out-performs sleep.

Why You Still Feel Tired Even After Taking Supplements — And Where NAD+ Actually Fits

You've cleaned up your diet. You're taking a multivitamin. Maybe you've added magnesium, ashwagandha, a B-complex, and now — because the internet keeps telling you to — an NAD+ precursor like NR or NMN. Your supplement drawer looks like a small pharmacy. And yet, by 3 p.m., you're still flat.

If that's where you are, the issue probably isn't that you need another supplement. The issue is that the fatigue is being misdiagnosed. NAD+ has become the catch-all explanation for low energy, but in most people it isn't the bottleneck. Before we talk about why, let's clarify what fatigue actually is from a clinical standpoint.

What Fatigue Actually Is

"Tired" is a symptom, not a diagnosis. In practice, persistent fatigue almost always traces back to one of a handful of underlying mechanisms — and each one has a different fix.

Iron deficiency, including functional deficiency. Low ferritin can cause fatigue long before hemoglobin drops enough to flag anemia on standard labs. Functional iron deficiency — where iron is present but unavailable for use due to inflammation — is also common and frequently missed. If ferritin is under ~30 ng/mL (some clinicians use higher cutoffs), fatigue is a reasonable expectation regardless of what supplements you take.

Thyroid dysfunction. Subclinical hypothyroidism, Hashimoto's, and undertreated thyroid disease produce a kind of fatigue that no amount of NAD+ will touch. TSH alone is not enough; free T4, free T3, and antibodies often need to be considered.

Cortisol dysregulation. Chronic stress flattens the natural cortisol curve. People wake up exhausted, get a second wind at night, and can't fall asleep. This pattern is behavioral and physiological — not a precursor deficiency.

Sleep architecture issues. You can spend eight hours in bed and still wake up tired if your sleep is fragmented, if you have undiagnosed sleep apnea, or if alcohol is suppressing REM. Sleep quantity without sleep quality is one of the most common reasons people feel chronically depleted.

Mitochondrial dysfunction. This is where NAD+ enters the conversation. Mitochondria produce ATP, the body's actual energy currency, and NAD+ is a coenzyme central to that process. When mitochondrial output drops — with age, in metabolic disease, or under sustained oxidative stress — fatigue can follow. The question is whether boosting NAD+ in healthy adults actually fixes that bottleneck. We'll get to it.

NAD+, Explained Simply

NAD+ (nicotinamide adenine dinucleotide) is a coenzyme present in every cell. Two of its jobs matter for the fatigue conversation: it shuttles electrons through the electron transport chain to help generate ATP, and it serves as a substrate for sirtuins and PARPs — enzymes involved in DNA repair and stress response.

NAD+ levels decline with age. They also drop in conditions involving chronic inflammation, metabolic dysfunction, and cellular stress. From there, the logic is intuitive: if NAD+ goes down and energy goes down, raise NAD+ and energy should come back up.

That logic is what built an entire supplement category. The problem is that biology isn't always that linear.

What the Research Actually Shows

The current human evidence — primarily small, short randomized controlled trials and a few systematic reviews from 2023–2026 — is consistent on one point and frustratingly inconsistent on another.

Consistent finding: NR and NMN reliably raise NAD+ in the blood. A 2026 PRISMA systematic review by Gallagher and colleagues, covering 33 human intervention studies, confirmed that oral NR and NMN engage the target. Zhang and colleagues (2025) reached the same conclusion in their meta-analysis. If the question is "does the supplement get into your system and shift the biomarker," the answer is yes.

Inconsistent finding: clinical outcomes don't reliably follow. That same 2026 review described the functional, metabolic, and vascular outcomes as heterogeneous and "often null or endpoint-specific." VO2max and grip strength were frequently unchanged. Fatigue and sleep results were mixed — some self-reported improvements, others nothing. The reviewers concluded that biochemical activity is clear, but clinical effectiveness for anti-aging and wellness use is inconclusive.

The long-COVID trial by Wu and colleagues (2025) is worth highlighting because it tested high-dose NR (2000 mg/day) in a population with persistent fatigue and cognitive symptoms — exactly the kind of patient who would, in theory, benefit. NAD+ rose 2.6 to 3.1 fold. And in the primary analysis, there was no significant between-group difference versus placebo for cognition, fatigue severity (p=0.59), sleep quality, or mood. Post-hoc within-group exploratory signals were noted, but the headline result was a null finding despite clear target engagement.

A more positive outlier is the Yi et al. (2023) RCT in healthy middle-aged adults, where 60 days of NMN at 300, 600, or 900 mg/day produced dose-dependent increases in NAD+ and significant improvement in 6-minute walk distance and self-reported health. So benefits are not zero — but they show up in submaximal performance and subjective measures, not in the broad "I have more energy" sense people are usually chasing.

The pattern is clear once you step back: the biomarker moves, but the person often doesn't feel different.

Why People Feel No Difference

A few things are likely happening at once.

The most common reason is the simplest one: the wrong root cause is being treated. If your fatigue is driven by low ferritin, undertreated thyroid disease, fragmented sleep, or chronic stress, raising NAD+ does not address any of those. You can saturate the pathway and still feel exhausted because the actual rate-limiting step is somewhere else entirely.

Second, NAD+ may not be the limiting factor in healthy adults to begin with. Cellular NAD+ pools are tightly regulated, and in someone without significant metabolic dysfunction, pushing levels higher doesn't necessarily change downstream output. More substrate doesn't help if the bottleneck is elsewhere on the assembly line.

Third, there are real questions about absorption and tissue targeting. Raising circulating NAD+ metabolites is not the same as raising NAD+ in the specific tissues — muscle, brain, liver — where it would need to act to change how you feel. Human pharmacokinetic data here is still maturing.

And fourth, there's a mismatch between expectation and biology. People expect a felt difference, the kind a stimulant produces. NAD+ precursors, even when they help, work slowly and at the level of cellular metabolism. That is not a sensation you can feel by Tuesday.

When NAD+ Might Actually Help

There are populations where the rationale is stronger and the data is more encouraging.

Older adults — particularly those over 60 — have measurably lower NAD+ levels and may see more functional benefit, especially in submaximal physical performance. Yi et al. fits this picture.

People with metabolic dysfunction, including insulin resistance and obesity, are another group where mitochondrial bottlenecks are more plausible and supplementation has a clearer mechanistic argument, though clinical trial outcomes remain mixed.

And in high-stress or burnout cases, where chronic cortisol elevation and sleep disruption have likely degraded mitochondrial function over time, NAD+ support as part of a larger plan is reasonable to consider. The key phrase is "part of a larger plan." It is not the foundation.

What I Would Actually Recommend, As a Pharmacist

When someone walks up to the counter exhausted, holding a bottle of NMN, here's the order of operations I'd actually use.

First, fix sleep. Not sleep quantity — sleep quality. Consistent schedule, cool dark room, no alcohol within three hours of bed, and a serious conversation about sleep apnea if there's snoring, witnessed pauses, or daytime sleepiness despite adequate hours. No supplement out-performs sleep.

Second, rule out deficiencies. Get bloodwork. At minimum: a CBC, ferritin, TSH with free T4 (free T3 and antibodies if symptoms warrant), vitamin D, vitamin B12, and a basic metabolic panel. These are the corrections that make a felt difference within weeks, because you're fixing the actual problem.

Third, support the nervous system. Chronic stress is fatigue's most underdiagnosed driver. This is where magnesium glycinate, attention to caffeine timing, and — when appropriate — clinical support for anxiety, depression, or trauma do far more than any precursor supplement.

Fourth, then consider NAD+ support. If sleep is solid, deficiencies are corrected, the nervous system is supported, and there's still a residual issue that fits the profile (older age, metabolic dysfunction, sustained burnout in recovery), then NR or NMN can be a reasonable addition. Not a starting point.

A Soft Recommendation Section

For most people walking through these steps, the supplements that earn their place are unglamorous.

Magnesium glycinate, typically 200–400 mg at night, supports sleep quality and helps with the muscle tension and anxiety side of stress. Glycinate is gentler on the gut than oxide or citrate.

Iron, but only if indicated by labs. Iron supplementation in someone who isn't deficient is at best useless and at worst harmful. If ferritin is low, it should be treated under guidance, with attention to form (ferrous bisglycinate is well tolerated) and dosing strategy (alternate-day dosing often improves absorption).

A B-complex, ideally with methylated forms (methylfolate, methylcobalamin) for people with relevant symptoms or known MTHFR variants. B vitamins are cofactors throughout energy metabolism, and they're cheap, well-studied, and directly relevant.

NR or NMN, optionally, in select cases. Older adults, people with metabolic dysfunction, or those in structured burnout recovery may consider it after the foundations are in place. Doses studied in trials range widely (NMN 250–900 mg, NR up to 1000–2000 mg in clinical contexts), short-term safety looks acceptable, but long-term outcomes data is limited. This is a "discuss with your physician" supplement, not a default.

Most people are not low in NAD+ — they're solving the wrong problem.

Second, rule out deficiencies. Get bloodwork. At minimum: a CBC, ferritin, TSH with free T4 (free T3 and antibodies if symptoms warrant), vitamin D, vitamin B12, and a basic metabolic panel. These are the corrections that make a felt difference within weeks, because you're fixing the actual problem.

Third, support the nervous system. Chronic stress is fatigue's most underdiagnosed driver. This is where magnesium glycinate, attention to caffeine timing, and — when appropriate — clinical support for anxiety, depression, or trauma do far more than any precursor supplement.

Fourth, then consider NAD+ support. If sleep is solid, deficiencies are corrected, the nervous system is supported, and there's still a residual issue that fits the profile (older age, metabolic dysfunction, sustained burnout in recovery), then NR or NMN can be a reasonable addition. Not a starting point.

A Soft Recommendation Section

For most people walking through these steps, the supplements that earn their place are unglamorous.

Magnesium glycinate, typically 200–400 mg at night, supports sleep quality and helps with the muscle tension and anxiety side of stress. Glycinate is gentler on the gut than oxide or citrate.

Iron, but only if indicated by labs. Iron supplementation in someone who isn't deficient is at best useless and at worst harmful. If ferritin is low, it should be treated under guidance, with attention to form (ferrous bisglycinate is well tolerated) and dosing strategy (alternate-day dosing often improves absorption).

B-complex, ideally with methylated forms (methylfolate, methylcobalamin) for people with relevant symptoms or known MTHFR variants. B vitamins are cofactors throughout energy metabolism, and they're cheap, well-studied, and directly relevant.

NR or NMN, optionally, in select cases. Older adults, people with metabolic dysfunction, or those in structured burnout recovery may consider it after the foundations are in place. Doses studied in trials range widely (NMN 250–900 mg, NR up to 1000–2000 mg in clinical contexts), short-term safety looks acceptable, but long-term outcomes data is limited. This is a "discuss with your physician" supplement, not a default.

Most people are not low in NAD+ — they're solving the wrong problem.

**This content is for informational and educational purposes only and does not constitute medical advice. It is not intended to diagnose, treat, cure, or prevent any condition. Always consult a qualified healthcare professional before starting any supplement, especially if you have underlying health conditions or take medications.

**Some links on this page are affiliate links. As a pharmacist, I only recommend products I trust and would use in real practice.

Privacy Policy

Terms & Conditions